Erlotinib

Information about Erlotinib

Erlotinib uses

Erlotinib is used in the treatment of pancreatic cancer and small cell lung cancer.

How erlotinib works

In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Erlotinib blocks this signal, and thus stops the production of these cancer cells.

Common side effects of erlotinib

Nausea, Vomiting, Fatigue, Breathing difficulty, Abdominal pain, Edema, Weight loss, Loss of appetite, Anemia, Infection, Bone pain, Constipation, Diarrhoea, Fever, Stomatitis (Inflammation of the mouth), Rash.

Available Medicine for Erlotinib

  • ₹9514 to ₹11900
    Natco Pharma Ltd
    2 variant(s)
  • ₹9281 to ₹11157
    Zydus Cadila
    2 variant(s)
  • ₹18767 to ₹30570
    Glenmark Pharmaceuticals Ltd
    2 variant(s)
  • ₹5314 to ₹18990
    Dr Reddy's Laboratories Ltd
    2 variant(s)
  • ₹11000
    Intas Pharmaceuticals Ltd
    1 variant(s)
  • ₹11159
    RPG Life Sciences Ltd
    1 variant(s)
  • ₹7714 to ₹10395
    Alkem Laboratories Ltd
    2 variant(s)
  • ₹25500
    Lupin Ltd
    1 variant(s)
  • ₹9003
    Reliance Life Sciences
    1 variant(s)
  • ₹6500 to ₹8500
    United Biotech Pvt Ltd
    2 variant(s)

Expert advice for Erlotinib

  • Erlotinib tablets should be taken either 1 hour before or 2 hours after ingestion of food.
  • Erlotinib is not recommended for children and adolescents under 18 years of age.
  • Stop smoking and use effective contraceptive measures while on erlotinib treatment.
  • Do not start erlotinib if you use contact lenses, have had eye problems (ulcers in front part of eye, dry eyes, inflammation in front part of eye), liver or kidney problems, Gilbert’s syndrome (liver disorder that causes increased bilirubin), intolerance to some sugars, are pregnant or breast-feeding.
  • Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe diarrhea, loss of appetite, nausea or vomiting, severe blistering or peeling of skin, severe pain in abdomen, acute or increasing pain and redness in eye, blurred vision or sensitivity to light, increased eye watering.

Frequently asked questions for Erlotinib

Erlotinib

Q. Is erlotinib FDA approved?
Yes, erlotinib is approved by FDA
Q. How long does erlotinib work?
A single dose of erlotinib works for around 36 hours.
Q. Is erlotinib cytotoxic, chemotherapeutic drug, biologic or monoclonal antibody?
Erlotinib is not a cytotoxic, chemotherapy drug, or monoclonal antibody. Erlotinib is a biologic tyrosine kinase inhibitor
Show More
Q. Does erlotinib cause neutropenia?
Yes, erlotinib can cause neutropenia

Content on this page was last updated on 02 May, 2017, by Dr. Varun Gupta (MD Pharmacology)